Treatment for Bile Duct Cancer in the Liver
NCT02167711
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Cholangio Carcinoma
Interventions
DRUG:
SIRT Yttrium-90
Sponsor
Chinese University of Hong Kong